Division of Endocrinology and Diabetology, Department of Internal Medicine II, University Hospital of Freiburg, Hugstetter Strasse 55, 79106 Freiburg, Germany.
Mol Cell Endocrinol. 2012 Nov 5;363(1-2):20-6. doi: 10.1016/j.mce.2012.07.003. Epub 2012 Jul 16.
Human Krüppel-like factor 11 (hKLF11) has been characterised to both activate and inhibit human insulin promoter (hInsP) activity. Since KLF11 is capable to differentially regulate genes dependent on recruited cofactors, we investigated the effects of hKLF11 on cotransfected hInsP in both β-cells and non-β-cells. hKLF11 protein interacts with hp300 but not with hPDX1. Overexpressed hKLF11 stimulates PDX1-transactivation of hInsP in HEK293 non-β-cells, but confers inhibition in INS-1E β-cells. Both hKLF11 functions can be neutralised by the p300 inhibitor E1A, increased hp300 levels (INS-1E), dominant negative (DN)-PDX1 and by mutation of the PDX1 binding site A3 or the CACCC box. In summary, hKLF11 differentially regulates hInsP activity depending on the molecular context via modulation of p300:PDX1 interactions with the A3 element and CACCC box. We postulate that KLF11 has a role in fine-tuning insulin transcription in certain cellular situations rather than representing a major transcriptional activator or repressor of the insulin gene.
人类 Kruppel 样因子 11(hKLF11)已被证实既能激活又能抑制人胰岛素启动子(hInsP)的活性。由于 KLF11 能够根据募集的共因子差异调节基因,我们研究了 hKLF11 在β细胞和非β细胞中转染 hInsP 的影响。hKLF11 蛋白与 hp300 相互作用,但不与 hPDX1 相互作用。过表达的 hKLF11 刺激非β细胞 HEK293 中的 hPDX1 对 hInsP 的反式激活,但在 INS-1Eβ细胞中赋予抑制作用。p300 抑制剂 E1A、hp300 水平升高(INS-1E)、显性负性(DN)-PDX1 和 PDX1 结合位点 A3 或 CACCC 盒的突变都可以中和 hKLF11 的这两种功能。总之,hKLF11 通过调节 p300:PDX1 与 A3 元件和 CACCC 盒的相互作用,根据分子背景差异调节 hInsP 活性。我们假设 KLF11 在某些细胞情况下在胰岛素转录的微调中起作用,而不是作为胰岛素基因的主要转录激活剂或抑制剂。